Nabisubi, Patricia
Kanyerezi, Stephen
Kebirungi, Grace
Sserwadda, Ivan
Nsubuga, Mike
Kisitu, Grace
Nahirya, Patricia Ntege
Mulindwa, Bonny
Akabwai, George P.
Nantongo, Sylvia
Kekitiinwa, Adeodata
Kigozi, Edgar
Luutu, Nsubuga Moses
Katabazi, Fred Ashaba
Kalema, Leymon
Katabalwa, Andrew
Jjingo, Daudi
Mboowa, Gerald
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TMA2020CDF-3159, TMA2020CDF-3159, TMA2020CDF-3159, TMA2020CDF-3159, TMA2020CDF-3159)
Article History
Received: 3 August 2024
Accepted: 16 January 2025
First Online: 21 January 2025
Declarations
:
: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. All study procedures involving human participants and sample collection were approved by the Infectious Diseases. Institute Research. Ethics Committee. (IDI-REC-046/2022) and the Uganda National Council for Science and Technology (UNCST), ensuring compliance with ethical standards and regulations. Informed consent and assent were obtained from all participants and their legal guardians before sample collection and inclusion.
: All the participants consented to the publication of their identifying data while they were consenting to participate in the study.
: The authors declare no competing interests.